STEROID-LEVELS IN CANCER OF THE PROSTATE - MARKERS OF TUMOR DIFFERENTIATION AND ADEQUACY OF ANTI-ANDROGEN THERAPY

被引：37
|
作者：
GELLER, J
ALBERT, J
LOZA, D
机构：
来源：
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY | 1979年 / 11卷 / 01期
关键词：
D O I：
10.1016/0022-4731(79)90092-X
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：631 / 636
页数：6
相关论文
共 50 条
  • [1] Androgen Metabolism and Response in Prostate Cancer Anti-Androgen Therapy Resistance
    Zhang, Haozhe
    Zhou, Yi
    Xing, Zengzhen
    Sah, Rajiv Kumar
    Hu, Junqi
    Hu, Hailiang
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (21)
  • [2] Third generation anti-androgen therapy of advanced prostate cancer
    Ohlmann, C. -H.
    Kamradt, J.
    Stoeckle, M.
    UROLOGE, 2012, 51 (04): : 522 - 526
  • [3] Prevalence of osteoporosis in patients with prostate cancer on anti-androgen therapy
    Senan Sanz, M. R.
    Haro Iniesta, L.
    Riel Cabrera, R.
    Olive Ferre, F. X.
    Biel Arrufat, A.
    Matinero Romero, E.
    SWISS MEDICAL WEEKLY, 2009, 139 (33-34) : 151S - 151S
  • [4] Anti-androgen monotherapy for metastatic prostate cancer
    Attard, Gerhardt
    LANCET ONCOLOGY, 2014, 15 (06): : 543 - 544
  • [5] EFFECTS OF ANTI-ANDROGEN THERAPY ON THE METASTATIC BEHAVIOR OF PROSTATE-CANCER
    HUTCHINS, GM
    DELAMONTE, SM
    MOORE, GW
    FEDERATION PROCEEDINGS, 1984, 43 (03) : 600 - 600
  • [6] Combining T-cell immunotherapy and anti-androgen therapy for prostate cancer
    C Sanchez
    R Chan
    P Bajgain
    S Rambally
    G Palapattu
    M Mims
    C M Rooney
    A M Leen
    M K Brenner
    J F Vera
    Prostate Cancer and Prostatic Diseases, 2013, 16 : 123 - 131
  • [7] The genomic evolution of prostate cancer under the selective pressure of anti-androgen therapy
    Gsponer, Joel Roman
    Dietsche, Tanja
    Rufle, Alexander
    Lorber, Thomas
    Juskevicius, Darius
    Perrina, Valeria
    Lenkiewicz, Elisabeth
    Zellweger, Tobias
    Bachmann, Alexander
    Barrett, Michael T.
    Rentsch, Cyrill A.
    Ruiz, Christian
    Bubendorf, Lukas
    CANCER RESEARCH, 2014, 74 (19)
  • [8] Combining T-cell immunotherapy and anti-androgen therapy for prostate cancer
    Sanchez, C.
    Chan, R.
    Bajgain, P.
    Rambally, S.
    Palapattu, G.
    Mims, M.
    Rooney, C. M.
    Leen, A. M.
    Brenner, M. K.
    Vera, J. F.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2013, 16 (02) : 123 - 131
  • [9] Clinical outcomes of anti-androgen withdrawal and subsequent alternative anti-androgen therapy for advanced prostate cancer following failure of initial maximum androgen blockade
    Momozono, Hiroyuki
    Miyake, Hideaki
    Tei, Hiromoto
    Harada, Ken-Ichi
    Fujisawa, Masato
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 4 (05) : 839 - 844
  • [10] Anti-Androgen Therapies for Prostate Cancer: A Focused Review
    Ammannagari, Nischala
    George, Saby
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2015, 11 (02) : 15 - 19
12345